Shares of Eden Research plc (LON:EDEN – Get Free Report) were up 2.8% during trading on Tuesday after an insider bought additional shares in the company. The stock traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares traded hands during trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey bought 540,540 shares of the firm’s stock in a transaction on Tuesday, January 28th. The shares were purchased at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Stock Performance
The company has a fifty day moving average of GBX 3.88 and a two-hundred day moving average of GBX 4.01. The company has a debt-to-equity ratio of 1.25, a quick ratio of 2.42 and a current ratio of 3.80. The company has a market cap of £19.73 million, a price-to-earnings ratio of -200.00 and a beta of 0.92.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
See Also
- Five stocks we like better than Eden Research
- Why Are Stock Sectors Important to Successful Investing?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Invest in the Best Canadian Stocks
- What Does the Future Hold for Eli Lilly?
- What is a Dividend King?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.